Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2021 earnings. Revenues increased 10% year-over-year to $11.6 billion. Net earnings attributable to Bristol Myers
Categories
pharma
Infographic: How Tilray (TLRY) performed in Q1 2022
Tilray (NASDAQ: TLRY) reported first-quarter 2022 financial results after the regular market hours on Thursday. Total net revenue increased 43% year-over-year to